Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia; South Australian Health and Medical Research Institute, Adelaide, South Australia, 5000, Australia.
Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia; South Australian Health and Medical Research Institute, Adelaide, South Australia, 5000, Australia.
Neoplasia. 2017 Dec;19(12):972-981. doi: 10.1016/j.neo.2017.09.004. Epub 2017 Nov 5.
Multiple myeloma (MM) is a hematological malignancy resulting from the uncontrolled proliferation of antibody-producing plasma cells in the bone marrow. At diagnosis, independent plasma cell tumors are found throughout the skeleton. The recirculation of mutant plasma cells from the initial lesion and their recolonization of distant marrow sites are thought to occur by a process similar to solid tumor metastasis. However, the efficiency of this bone marrow homing process and the proportion of disseminated cells that actively divide and contribute to new tumor growth in MM are both unknown. We used the C57BL/KaLwRij mouse model of myeloma, lentiviral-mediated DNA barcoding of 5TGM1 myeloma cells, and next-generation sequencing to investigate the relative efficiency of plasma cell migration to, and growth within, the bone marrow. This approach revealed three major findings: firstly, establishment of metastasis within the bone marrow was extremely inefficient, with approximately 0.01% of circulating myeloma cells becoming resident long term in the bone marrow of each long bone; secondly, the individual cells of each metastasis exhibited marked differences in their proliferative fates, with the majority of final tumor burden within a bone being attributable to the progeny of between 1 and 8 cells; and, thirdly, the proliferative fate of individual clonal plasma cells differed at each bone marrow site in which the cells "landed." These findings suggest that individual myeloma plasma cells are subjected to vastly different selection pressures within the bone marrow microenvironment, highlighting the importance of niche-driven factors, which determine the disease course and outcome.
多发性骨髓瘤(MM)是一种血液系统恶性肿瘤,由骨髓中产生抗体的浆细胞不受控制地增殖引起。在诊断时,独立的浆细胞瘤可在整个骨骼中发现。突变浆细胞从初始病变部位的再循环及其在远处骨髓部位的重新定植被认为是通过类似于实体瘤转移的过程发生的。然而,这种骨髓归巢过程的效率以及主动分裂并有助于 MM 中新肿瘤生长的播散细胞的比例均未知。我们使用 C57BL/KaLwRij 骨髓瘤小鼠模型、5TGM1 骨髓瘤细胞的慢病毒介导 DNA 条形码和下一代测序来研究浆细胞向骨髓迁移和在骨髓中生长的相对效率。该方法揭示了三个主要发现:首先,骨髓内转移的建立效率极低,约有 0.01%的循环骨髓瘤细胞在每根长骨的骨髓中长期定居;其次,每个转移中的单个细胞在其增殖命运上存在明显差异,大多数最终肿瘤负担归因于骨内 1 到 8 个细胞的后代;第三,单个克隆浆细胞在其“着陆”的每个骨髓部位的增殖命运不同。这些发现表明,单个骨髓瘤浆细胞在骨髓微环境中受到截然不同的选择压力,突出了龛位驱动因素的重要性,这些因素决定了疾病的进程和结果。